SOPH - SOPHiA GENETICS S.A.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.50
DETAILS
HIGH:
$8.00
LOW:
$7.00
MEDIAN:
$7.50
CONSENSUS:
$7.50
UPSIDE:
53.69%
About SOPHiA GENETICS S.A. (https://www.sophiagenetics.com)
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Jurgi Camblong | Co-Founder, Chief Executive Officer & Director | 1979 | $1,238,055 USD |
| Abhimanyu Verma | EVP & Chief Technology Officer | – | – |
| Daan van Well | Executive VP and Chief Legal & Compliance Officer | 1975 | – |
| George A. Cardoza | Executive Vice President & Chief Financial Officer | 1962 | – |
| Kellen Sanger | Head of Strategy and Investor Relations | – | – |
| Kevin Puylaert | SVP & Chief Sales Officer | – | – |
| Manuela Da Silva Valente | Executive Vice President & Chief People Officer | 1971 | – |
| Philippe Menu | Executive Vice President, Chief Medical Officer & Chief Product Officer | 1982 | – |
| Ross Jordan Muken | President | 1981 | – |
| Zhenyu Xu | Executive Vice President & Chief Scientific Officer | 1983 | – |